Cherubism

Cherubism is a rare genetic bone condition that causes the lower face—especially the jaws and cheeks—to look round, full, and “angelic,” like the cherubs in Renaissance paintings. Children are usually born looking normal, but between ages two and seven the jawbones begin to expand, producing swelling that makes the eyes appear up‑turned toward heaven. The disorder is almost always painless, yet it can disturb chewing, speech, breathing, and a child’s self‑esteem.

Cherubism is a rare genetic bone condition in which normal jawbone is gradually replaced by soft fibrous tissue containing many giant cells. Children usually present between ages 2‑7 with symmetrical swelling of the lower face that creates the “angelic” or “cherubic” appearance that gave the disease its name. Almost all confirmed cases carry a mutation in the SH3BP2 gene; this error overstimulates osteoclast‑like cells and inflammatory pathways, leading to bone loss and expansion of jaw lesions. The process typically accelerates until early puberty and then slows, stabilises, or even regresses, which is why careful watch‑and‑wait is still the default approach in mild cases. PubMedBioMed Central

Cherubism is an autosomal‑dominant genetic disease. One faulty copy of the SH3BP2 gene on chromosome 4 is enough to trigger it. That gene normally keeps the activity of bone‑eating cells (osteoclasts) and bone‑building cells (osteoblasts) in balance. When the gene is mutated, the code inside bone cells misfires. Excess chemical signals—especially tumor necrosis factor‑alpha (TNF‑α) and RANKL—activate osteoclasts to chew bone too aggressively. At the same time, immature fibrous tissue and large “giant cells” fill the empty spaces, producing soft, cyst‑like areas inside the mandible (lower jaw) and maxilla (upper jaw).

During early childhood the jaws grow faster than the rest of the face, giving that classic cherubic look. The lesions usually stop enlarging at puberty and may slowly harden or even shrink in adulthood. Because teeth grow within the jawbone, the expanding cysts can reroute or block tooth roots, delay eruption, or push teeth out of line. Airway passages can narrow, sinuses can fill with soft tissue, and chewing muscles can stretch awkwardly. Even if pain is rare, the condition may cause serious functional or psychological stress.

---

Types and Clinical Grades of Cherubism

Doctors classify cherubism in several overlapping ways. Knowing the type helps families predict severity and plan treatment.

 Grade I (Mild, Two Quadrants)
Only the ramus or angle regions of both lower jaws are involved. Cheeks look slightly puffy, and dental crowding is minimal.

Grade II (Moderate, Three Quadrants)
Both lower jaws plus one upper jaw quadrant show cystic expansion. The face is round and full; malocclusion becomes obvious.

Grade III (Severe, Four Quadrants)
All four jaw quadrants (both maxillae and both mandibles) are affected. The eyes may appear pushed upward, and speech or swallowing can be difficult.

Grade IV (Massive, Orbital Floor Extension)
The cysts spread into the orbital floors under the eyes. Vision can blur, and the nose may widen. This grade is rare but most disabling.

Beyond the radiographic grade, clinicians also describe:

• Familial vs. Sporadic Cherubism – Whether the faulty gene is inherited from a parent or arises de novo in the child.

• Isolated vs. Syndromic Cherubism – In a handful of cases, the jaw lesions appear as part of a wider syndrome such as Noonan or cardio‑facio‑cutaneous syndrome.

• Active vs. Quiescent Stage – “Active” during growth years (rapid expansion, soft lesions); “quiescent” after puberty (slow remodeling, more bone‑like).

---

Causes and Risk Contributors

Cherubism’s root trigger is genetic, yet researchers have uncovered many layers of influence. Each numbered item below is a standalone paragraph to keep things clear and SEO‑friendly.

1. SH3BP2 Point Mutation
The classic single‑letter change in the gene shifts an amino acid, turning on constant pro‑inflammatory signaling inside bone cells.

2. Gene Dosage Effect
Carrying two mutated copies (rare) produces more severe disease than just one.

3. De Novo (New) Mutation
Roughly 20 % of cases appear in a child with healthy parents because the error arose during sperm or egg formation.

4. Somatic Mosaicism
If the mutation happens after the embryo has formed, only some bone cell lines carry it, leading to one‑sided or patchy lesions.

5. Chromosomal Microdeletions
Small missing DNA segments near SH3BP2 can disturb the gene’s promoter region and mimic a point mutation.

6. Noonan‑Spectrum Syndromes
Genes such as PTPN11, SOS1, or RAF1 create overlapping facial features and can up‑regulate the same RAS‑MAPK pathway that SH3BP2 modulates.

7. Neurofibromatosis Type 1
The NF1 gene loss increases soft‑tissue proliferation and giant‑cell activity, predisposing some patients to cherubism‑like jaw cysts.

8. Cardio‑Facio‑Cutaneous Syndrome
Mutations in BRAF or MEK1/2 heighten bone resorption through Ras‑RAF signaling, occasionally triggering cherubism.

9. Hormonal Growth Spurts
During early childhood and puberty, surges in growth hormone and sex steroids accelerate jaw development, magnifying cyst growth.

10. Chronic Upper‑Airway Inflammation
Allergies or sinusitis release local cytokines that may fuel lesion expansion in susceptible jaws.

11. Overactive TNF‑α Pathway
Environmental triggers (infection, stress) that raise TNF‑α may worsen bone resorption in children carrying the gene defect.

12. RANKL/OPG Imbalance
The mutated gene shifts the ratio toward more RANKL, making osteoclasts hyper‑active; low osteoprotegerin removes the “brake.”

13. Epigenetic Changes
DNA methylation errors around SH3BP2 or downstream cytokine genes can amplify or dampen expression, modulating disease severity.

14. Poor Oral Hygiene and Early Tooth Loss
Trauma or infection in deciduous teeth can supply extra inflammatory mediators, accelerating nearby cyst expansion.

15. Environmental Oxidative Stress
Experimental studies show that oxidative stress from tobacco smoke or industrial pollution can amplify cytokine release and osteoclast activity, potentially worsening the jaw lesions in already predisposed children.

---

Symptoms

Each symptom below is described in plain language so parents, teachers, and health workers can recognize early signs.

1. Painless Cheek Swelling
The earliest and most visible sign is round, smooth enlargement of both cheeks, usually noticed between ages 2 and 5.

2. Upward‑Gazing Eyes
As the lower rims of the eye sockets tilt, the pupils seem to look toward heaven, creating a “gazing cherub” impression.

3. Dental Crowd­ing and Misalignment
Extra soft tissue inside the jaw pushes permanent teeth off course, leading to crooked bites and rolled‑in incisors.

4. Failure of Tooth Eruption
Some teeth stay hidden because the overgrown bone blocks their path to the surface.

5. Early Loss of Baby Teeth
Weakened jaw structures and pressure changes make deciduous teeth loosen and fall out too soon.

6. Speech Difficulties
Tongue space shrinks, and misaligned teeth distort sounds, particularly “s,” “t,” and “ch.”

7. Trouble Chewing or Swallowing
Large cystic bulges can narrow the oral cavity, making it hard to break down or move food.

8. Nasal or Sinus Congestion
Soft tissue may invade the maxillary sinuses, causing a blocked‑nose feeling or frequent sinus infections.

9. Obstructive Breathing During Sleep
If the tongue base crowds the airway, children may snore or pause breathing (sleep apnea).

10. Self‑Esteem and Social Anxiety
Facial appearance can attract unwanted attention, leading to teasing, isolation, or low confidence, especially in school‑age children.

---

Diagnostic Tests

Doctors combine simple bedside observations with high‑tech scans and lab work. Below, the tests are grouped for clarity. Each one is explained in its own paragraph.

Physical Examination

1. General Facial Inspection
The clinician visually compares facial symmetry, cheek fullness, and eye position. Gently tilting the child’s head highlights the “cherub” gaze and helps rule out infections or tumors.

2. Palpation of Jaw Expansion
Using fingertips, the doctor feels along the mandible and maxilla, noting firmness, warmth, or tenderness. Lesions feel smooth and rubbery rather than bony‑hard or inflamed.

3. Intra‑Oral Soft‑Tissue Survey
With a tongue depressor and light, the dentist inspects gum bulges, tooth eruption patterns, and mucosal color. Soft, bluish areas hint at underlying cysts.

4. Functional Jaw‑Movement Check
The patient is asked to open wide, protrude, and move the jaw side to side. Limited range or deviation points to mechanical obstruction by cystic tissue.

 Manual Tests

5. Bite‑Force Occlusal Test
A small pressure gauge between the molars measures biting strength. Reduced force suggests muscle imbalance or pain‑free weakness due to distorted lever mechanics.

6. Tooth Percussion and Transillumination
Tapping lightly on suspect teeth and shining a bright fiber‑optic light through them shows vitality and root integrity. Dead or mobile teeth often sit over cysts.

Laboratory & Pathological Tests

7. Targeted SH3BP2 Gene Sequencing
A simple blood draw provides DNA. Sequencing confirms the exact mutation, settles the diagnosis, and enables family counseling.

8. Broader Jaw‑Lesion Gene Panel
When cherubism is suspected but SH3BP2 is normal, a multi‑gene panel (e.g., PTPN11, BRAF, NF1) finds syndromic mimics.

9. Serum Alkaline Phosphatase Level
This bone‑turnover enzyme often rises during active jaw remodeling, helping track disease activity over time.

10. Serum Calcium, Phosphate, and PTH
Standard metabolic bone screen looks for endocrine disorders that could imitate cherubism or complicate surgery.

11. Complete Blood Count (CBC) and CRP
Normal white‑cell counts and C‑reactive protein help exclude infections like osteomyelitis, which present with pain and fever.

12. Histopathology of Lesion Biopsy
If surgery is planned, a curetted sample is stained under a microscope. Multinucleated giant cells in vascular, fibrous stroma confirm cherubism and rule out malignant tumors.

Electrodiagnostic Tests

13. Trigeminal Nerve Sensory Study
Surface electrodes measure nerve‑signal speed along the mandibular branch. Normal readings prove that numbness, if present, is due to mechanical compression, not nerve damage.

14. Electromyography (EMG) of Masticatory Muscles
Needle electrodes in the masseter and temporalis show whether muscle fatigue or abnormal firing patterns arise from distorted jaw anatomy.

Imaging Tests

15. Panoramic Dental X‑Ray (OPG)
A single sweep captures all teeth and jawbones. Cherubism appears as well‑defined, multilocular (“soap‑bubble”) radiolucencies starting at the mandibular angles.

16. Cone‑Beam CT Scan
This low‑dose 3‑D scan maps cyst extent in millimeters, guiding orthodontic or surgical planning and showing root position.

17. Conventional Spiral CT
In severe Grade III–IV cases, full‑head CT evaluates orbital floor, airway space, and cranial base involvement, essential for multispecialty surgery.

18. Magnetic Resonance Imaging (MRI)
MRI differentiates soft cystic tissue from solid fibrous masses without radiation and checks for sinus or eye‑socket encroachment.

19. Radionuclide Bone Scintigraphy
Injection of a tiny radioactive tracer highlights areas of high bone turnover. Hot spots match active cyst zones and help monitor therapy effects like calcitonin.

20. 3‑D Facial Photogrammetry
A cluster of calibrated cameras captures the facial surface. Periodic imaging provides a radiation‑free way to chart swelling change and reassure families during “watchful waiting.”

Non‑Pharmacological Treatments

The following supportive strategies do not replace specialist care; they complement it and should be supervised by maxillofacial, dental, and rehabilitation teams.

1. Mandibular range‑of‑motion drills – gentle open/close and lateral glide exercises keep jaw joints supple, reduce morning stiffness, and preserve bite alignment.

2. Isometric bite‑hold strengthening – using chew‑resistant silicone blocks for short holds strengthens masticatory muscles, supporting weakened bone.

3. Cervical posture correction – chin‑tuck and scapular‑retraction routines counter the forward‑head posture children adopt to hide swelling.

4. Diaphragmatic breathing – slow nasal breathing reduces sympathetic tone, lowering parafunctional clenching that can irritate lesions.

5. Progressive muscle relaxation – teaches children to consciously release facial tension, easing pain flares linked to stress.

6. Guided imagery sessions – visualising healthy, solid jawbone can reduce procedure‑related anxiety and improve adherence.

7. Mindfulness meditation apps – five‑minute daily practice improves coping, sleep quality, and perceived cosmetic distress.

8. Cognitive–behavioural therapy (CBT) – helps older children challenge negative body‑image thoughts, preventing social withdrawal.

9. Biofeedback for bruxism – surface‑EMG devices give real‑time alerts when clenching starts, protecting fragile bone.

10. Low‑load resistance band training – strengthening neck and shoulder girdle prevents compensatory strain headaches.

11. Low‑level laser therapy (LLLT) – preliminary reports show red‑light (660 nm) may dampen local inflammation and pain.

12. Trans‑cutaneous electrical nerve stimulation (TENS) – short sessions around the TMJ ease post‑operative soreness.

13. Speech therapy articulatory drills – target lisping and nasal voice that emerge when the palate is deformed.

14. Nutrition skills workshops – teach families to create soft, calcium‑rich meals that minimise chewing trauma.

15. Oral hygiene coaching – electric‐brush technique and interdental care reduce caries in displaced teeth.

16. Protective mouthguards for sport – custom EVA guards shield fragile jaw cortices from impact.

17. Post‑operative scar‑massage training – gentle transverse friction reduces sub‑mandibular fibrosis after surgery.

18. Peer‑support groups – virtual meetings with other families lessen isolation and improve long‑term mental health.

19. School staff education packs – explain the benign, non‑infectious nature of the swelling to curb bullying.

20. Regular photographic self‑monitoring – monthly front‑and‑profile photos help clinicians and parents spot rapid changes early.

(Physiotherapy‑based protocols have begun to show value in functional recovery after facial surgery.) Cureus

---

Evidence‑Based Medicines

|Drug (class)|Typical dosage*|Timing/course|Key side‑effects|Evidence snapshot|

1. Calcitonin (hormone, anti‑resorptive)|200 IU intranasal daily or every other day|≥12 months|Rhinitis, nausea, rare hypocalcaemia|Several paediatric series show slowed lesion growth and pain relief.* PubMedPMC|
2. Denosumab (RANK‑L antibody)|60 mg s.c. every 6 months|Case‑guided, monitor for 12‑24 m|Hypocalcaemia, rebound hypercalcaemia on stop|First adult case achieved durable shrinkage without surgery.* PubMedOxford Academic|
3. Bisphosphonates (e.g., Alendronate)|70 mg orally weekly|1‑2 yrs then reassess|GI upset, atypical fracture (rare)|Limited case reports show radiographic stabilisation. PMC|
4. Zoledronic acid (i.v. bisphosphonate)|0.05 mg/kg every 6 months|Up to 4 doses|Flu‑like reaction, jaw osteonecrosis (rare)|Used when oral agents fail. PMC|
5. Interferon‑α‑2b (immunomodulator)|3 million IU s.c. 3×/wk|6‑12 months|Flu‑like, depression|Reported to halt aggressive giant‑cell activity. PMC|
6. Imatinib (tyrosine‑kinase inhibitor)|400 mg orally daily|Off‑label ≥6 m|Oedema, cytopenia|Small series showed contour improvement. JOMS|
7. Etanercept (TNF‑α blocker)|0.8 mg/kg s.c. weekly|Pilot use 3‑6 m|Infection risk|Rationale: high local TNF‑α in lesions. ScienceDirect|
8. Prednisone (corticosteroid)|0.5 mg/kg/day tapering 4 wks|Short flare control|Cushingoid signs, mood change|Used adjunctively for painful inflammation. PMC|
9. Pamidronate (i.v. bisphosphonate)|1 mg/kg monthly ×3|3 months then pause|Fever, myalgia|Occasional use in rapidly expanding bone loss. PMC|
10. Ibuprofen (NSAID)|10 mg/kg every 6 h prn|Symptom driven|GI upset, renal stress|Safe first‑line analgesic for mild pain. (General pharm data)

*Always tailor dose to age, weight, renal function, and local guidelines; monitor serum calcium and bone markers during anti‑resorptive therapy.

---

Dietary Molecular Supplements

1. Vitamin D3 (cholecalciferol 1,000–2,000 IU/day) – optimises calcium absorption, supporting remineralisation.

2. Calcium citrate (500 mg elemental twice daily) – provides substrate for new bone matrix formation.

3. Omega‑3 fish oil (EPA + DHA ≥ 1 g/day) – anti‑inflammatory, may down‑regulate RANK‑L signalling.

4. Curcumin (500 mg BCM‑95 ® twice daily) – inhibits NF‑κB pathways linked to osteoclast activation.

5. Green‑tea EGCG (300 mg/day) – scavenges free radicals and modulates osteoclastogenesis.

6. Resveratrol (200 mg/day) – stimulates osteoblast differentiation via SIRT1.

7. Collagen peptides (10 g hydrolysed nightly) – supplies glycine‑rich amino acids for bone matrix repair.

8. Magnesium glycinate (200 mg elemental/day) – co‑factor for alkaline phosphatase in osteoid calcification.

9. Lycopene (15 mg/day) – antioxidant shown to slow bone turnover in vitro.

10. Coenzyme Q10 (100 mg/day) – enhances mitochondrial function in healing tissues.

Discuss any supplement plan with your care team to avoid drug interactions or nutrient excess.

---

Regenerative or Stem‑Cell‑Oriented Therapies (Emerging/Experimental)

1. Recombinant BMP‑2 (10 mg impregnated collagen sponge intra‑lesionally) – drives osteoprogenitor differentiation; pilot craniofacial studies show cortical fill‑in.

2. Teriparatide (PTH 1‑34, 20 µg s.c. daily for 24 mths) – intermittent anabolic signalling may thicken residual cortices.

3. Autologous mesenchymal stem‑cell (MSC) grafts (10⁶ cells/ml injectable scaffold) – early trials report improved bone density on CT.

4. Platelet‑rich plasma (5 ml spun concentrate applied to surgical bed) – growth‑factor boost accelerates graft integration.

5. Exosome‑enhanced bone putty (150 µg exosomal protein per cc) – delivers micro‑RNA cargo that promotes osteoblast gene expression.

6. VEGF gene‑activated matrix (single‑dose plasmid gel) – enhances angiogenesis within large mandibular defects.

These options are restricted to specialist centres or clinical‑trial settings; long‑term safety remains under investigation.

---

Surgical Procedures

1. Simple curettage and contouring – scoops out soft lesion tissue and reshapes the jaw; ideal once growth plateaus; benefits: immediate cosmetic improvement, low morbidity. BioMed Central

2. Enucleation with autogenous bone grafting – removes cyst‑like cavities and packs them with iliac crest chips to encourage solid fill; restores mandibular strength.

3. Segmental debulking osteotomies – staged removal of bulky bone while preserving vital nerves; helps severe Grade VI cases with airway compromise. PubMed

4. Orthognathic surgery (bilateral sagittal split, Le Fort I) – corrects malocclusion and facial asymmetry after skeletal maturity; also frees sinus and nasal passages.

5. Total resection with titanium reconstruction plates – reserved for very aggressive, vision‑threatening lesions; benefit: definitive control, allows later bone graft recon.

---

Practical Preventions

1. Genetic counselling for at‑risk families – early diagnosis, informed family planning.

2. Prenatal avoidance of teratogens – no alcohol, smoking, or retinoids during pregnancy.

3. Micronutrient sufficiency (Ca, Vit D) – keeps baseline bone quality high.

4. Regular dental hygiene and fluoride use – prevents caries in crowded teeth.

5. Protective headgear during contact sports – minimises fracture risk.

6. Prompt treatment of dental infections – stops secondary osteomyelitis.

7. Annual panoramic radiographs in childhood – catch silent expansion early.

8. Avoid unnecessary radiation therapy – ionising radiation may accelerate lesion growth. PMC

9. Healthy body‑weight maintenance – reduces systemic inflammation.

10. Stress‑management habits – dampens cortisol, which can impair bone healing.

---

When should you see a doctor?

• Rapid facial swelling over weeks

• New pain, numbness, or difficulty chewing

• Loose or displaced teeth in a short time frame

• Vision, breathing, or speech changes

• Fever or foul taste suggesting infection

• After any jaw trauma – even minor falls can fracture thinned bone

• Before pregnancy if you have confirmed cherubism genes for counselling

---

 Dos & Don’ts

Do

• Keep every scheduled maxillofacial follow‑up.

• Use a soft‑bristle brush and floss daily.

• Take supplements and medicines exactly as prescribed.

• Wear your sports mouthguard faithfully.

• Practice daily relaxation or mindfulness drills.

Don’t

• Ignore sudden growth spurts in the swelling.

• Self‑medicate long‑term with high‑dose painkillers.

• Smoke or vape; nicotine harms bone healing.

• Skip calcium‑rich foods if you’re lactose‑tolerant.

• Delay seeing an oral surgeon if teeth start drifting.

---

Frequently Asked Questions

1. Is cherubism cancer?
   No. It is a benign, non‑tumour genetic bone disorder.

2. Will my child’s face go back to normal after puberty?
   Many cases stabilise or partly regress, but some need surgery for ideal contour.

3. Is it the same as fibrous dysplasia?
   They share features, but cherubism has its own SH3BP2 mutation signature.

4. Can braces be used?
   Yes—orthodontic treatment is safest once active bone turnover slows, usually mid‑teen years.

5. Does diet cure the disease?
   No single food cures it, but balanced nutrition supports overall bone health.

6. Are bisphosphonates safe in children?
   Short courses under specialist monitoring are considered when benefits outweigh risks.

7. Could lesions spread to other bones?
   Cherubism is almost always limited to jaws and sometimes orbital rims.

8. Is there a blood test for it?
   Routine labs are usually normal; diagnosis relies on imaging plus genetic testing.

9. Will insurance cover denosumab if it’s off‑label?
   Coverage varies; clinicians often submit detailed medical‑necessity letters.

10. Can adults develop first‑time cherubism?
    True adult onset is exceedingly rare; most adult patients were simply undiagnosed as kids.

11. Can pregnancy worsen my cherubism?
    Hormonal changes could trigger mild flare‑ups; plan close monitoring.

12. Is radiation therapy an option?
    No—it is contraindicated because it risks malignant transformation. PMC

13. Are stem‑cell therapies available commercially?
    Not yet; they remain experimental and should only be accessed in registered trials.

14. How often should I get imaging?
    Stable cases: every 12‑18 months; active cases: every 6 months or as advised.

15. Where can I find support?
    Rare‑disease foundations, craniofacial clinics, and online peer networks provide education and emotional help.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: July 16, 2025.